10-Q Filing

IDEXX LABORATORIES INC /DE CIK: 874716 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0000874716-21-000031`
Period End Date	20210331
Filing Date	20210504
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	idxx-20210331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 36 Cash Flow Statement 58 Stockholders Equity 26 Comprehensive Income 34

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$351.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$383.93M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	106.46M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	106.68M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	85.45M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$331.43M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$381.79M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	85.36M	shares	Point-in-time
Inventories	`InventoryNet`	$225.56M	USD	Point-in-time
Inventories	`InventoryNet`	$209.87M	USD	Point-in-time
Deferred stock units, outstanding (in shares)	`CommonStockOtherSharesOutstanding`	87,000.00	shares	Point-in-time
Deferred stock units, outstanding (in shares)	`CommonStockOtherSharesOutstanding`	87,000.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$137.51M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$139.28M	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	21.31M	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	21.01M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.10B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.06B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$543.96M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$555.17M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$93.56M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$91.17M	USD	Point-in-time
Goodwill	`Goodwill`	$243.35M	USD	Point-in-time
Goodwill	`Goodwill`	$242.59M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$52.54M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$53.97M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$295.50M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$289.60M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$1.23B	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$1.23B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.29B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.33B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$74.56M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$87.17M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$366.88M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$415.65M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$49.99M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$124.97M	USD	Point-in-time
Current portion of deferred revenue	`ContractWithCustomerLiabilityCurrent`	$42.57M	USD	Point-in-time
Current portion of deferred revenue	`ContractWithCustomerLiabilityCurrent`	$41.64M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$582.76M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$620.66M	USD	Point-in-time
Deferred income tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$11.71M	USD	Point-in-time
Deferred income tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$18.57M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$858.49M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$778.75M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$46.16M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$44.23M	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$78.19M	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$77.04M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$83.55M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$85.60M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.00B	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$1.08B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.66B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.62B	USD	Point-in-time
Commitments and Contingencies (Note 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 15)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued:106,676 shares in 2021 and 106,457 shares in 2020; Outstanding: 85,365 shares in 2021 and 85,449 shares in 2020	`CommonStockValue`	$10.67M	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued:106,676 shares in 2021 and 106,457 shares in 2020; Outstanding: 85,365 shares in 2021 and 85,449 shares in 2020	`CommonStockValue`	$10.65M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.29B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.32B	USD	Point-in-time
Deferred stock units: Outstanding: 87 units in 2021 and 87 units in 2020	`CommonStockOtherValueOutstanding`	$4.55M	USD	Point-in-time
Deferred stock units: Outstanding: 87 units in 2021 and 87 units in 2020	`CommonStockOtherValueOutstanding`	$4.50M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.38B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.18B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-53.62M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-59.54M	USD	Point-in-time
Treasury stock, at cost: 21,311 shares in 2021 and 21,008 shares in 2020	`TreasuryStockValue`	$2.80B	USD	Point-in-time
Treasury stock, at cost: 21,311 shares in 2021 and 21,008 shares in 2020	`TreasuryStockValue`	$2.95B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity	`StockholdersEquity`	$702.70M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity	`StockholdersEquity`	$632.09M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$707.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$739.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$177.82M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$703.43M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$108.06M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$632.79M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$2.29B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$2.33B	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$777.71M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$626.34M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$266.75M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$306.93M	USD	1 Quarter
Gross profit	`GrossProfit`	$470.78M	USD	1 Quarter
Gross profit	`GrossProfit`	$359.59M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$114.81M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$116.14M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$70.77M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$65.81M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$37.58M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$33.31M	USD	1 Quarter
Operating Income (Loss), Total	`OperatingIncomeLoss`	$247.62M	USD	1 Quarter
Operating Income (Loss), Total	`OperatingIncomeLoss`	$144.32M	USD	1 Quarter
Interest expense	`InterestExpense`	$7.69M	USD	1 Quarter
Interest expense	`InterestExpense`	$7.58M	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$52.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$140.00K	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$136.77M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$240.09M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$24.92M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$35.80M	USD	1 Quarter
Net income	`ProfitLoss`	$204.29M	USD	1 Quarter
Net income	`ProfitLoss`	$111.86M	USD	1 Quarter
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$29.00K	USD	1 Quarter
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$32.00K	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$111.83M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$204.26M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.39	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.31	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.29	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.35	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	85.43M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	85.53M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	86.70M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	86.92M	shares	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$204.29M	USD	1 Quarter
Net income	`ProfitLoss`	$111.86M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.06M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$23.20M	USD	1 Quarter
Provision for credit losses	`ProvisionForLoanLeaseAndOtherLosses`	$186.00K	USD	1 Quarter
Provision for credit losses	`ProvisionForLoanLeaseAndOtherLosses`	$4.23M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$2.85M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$5.24M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$7.28M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$8.88M	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$333.00K	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$-13.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$54.73M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$38.06M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$14.43M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$7.92M	USD	1 Quarter
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$57.08M	USD	1 Quarter
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$64.88M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$2.46M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-1.75M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-2.29M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-2.41M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$27.87M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$124.42M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.16M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$49.00M	USD	1 Quarter
Acquisition of intangible assets and equity investment	`PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments`	-	USD	1 Quarter
Acquisition of intangible assets and equity investment	`PaymentsToAcquireIntangibleAssetsAndEquityMethodInvestments`	$668.00K	USD	1 Quarter
Acquisitions of a business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$4.42M	USD	1 Quarter
Acquisitions of a business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-49.67M	USD	1 Quarter
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-24.59M	USD	1 Quarter
Borrowings on revolving credit facilities, net	`ProceedsFromLinesOfCredit`	-	USD	1 Quarter
Borrowings on revolving credit facilities, net	`ProceedsFromLinesOfCredit`	$198.11M	USD	1 Quarter
Repurchases of common stock, net	`PaymentsForRepurchaseOfCommonStock`	$132.26M	USD	1 Quarter
Repurchases of common stock, net	`PaymentsForRepurchaseOfCommonStock`	$182.81M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$17.59M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$10.21M	USD	1 Quarter
Shares withheld for statutory tax withholding on restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$14.98M	USD	1 Quarter
Shares withheld for statutory tax withholding on restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$8.60M	USD	1 Quarter
Net cash (used) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-129.65M	USD	1 Quarter
Net cash (used) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.90M	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.95M	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-4.03M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-8.93M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-32.77M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$81.39M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$90.33M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$383.93M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$351.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$81.39M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$90.33M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$383.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$351.16M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$12.17M	USD	1 Quarter
Cash paid for income taxes	`IncomeTaxesPaid`	$12.02M	USD	1 Quarter
Unpaid property and equipment, reflected in accounts payable and accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$6.59M	USD	1 Quarter
Unpaid property and equipment, reflected in accounts payable and accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$14.12M	USD	1 Quarter

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Balance beginning of period (in shares)	`CommonStockSharesIssued`	106.46M	shares	Point-in-time
Balance beginning of period (in shares)	`CommonStockSharesIssued`	106.68M	shares	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$177.82M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$703.43M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$108.06M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$632.79M	USD	Point-in-time
Net income	`ProfitLoss`	$204.29M	USD	1 Quarter
Net income	`ProfitLoss`	$111.86M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-9.06M	USD	1 Quarter
Other comprehensive loss, net	`OtherComprehensiveIncomeLossNetOfTax`	$-5.92M	USD	1 Quarter
Repurchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$187.77M	USD	1 Quarter
Repurchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$154.03M	USD	1 Quarter
Common stock issued under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$17.43M	USD	1 Quarter
Common stock issued under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$9.75M	USD	1 Quarter
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$8.88M	USD	1 Quarter
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.28M	USD	1 Quarter
Balance end of period (in shares)	`CommonStockSharesIssued`	106.46M	shares	Point-in-time
Balance end of period (in shares)	`CommonStockSharesIssued`	106.68M	shares	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$177.82M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$703.43M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$108.06M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$632.79M	USD	Point-in-time

Comprehensive Income 34 line items

Line Item	Tag	Value	Unit	Period
Unrealized gain on Euro-denominated notes, tax expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax`	$1.15M	USD	1 Quarter
Net income	`ProfitLoss`	$204.29M	USD	1 Quarter
Net income	`ProfitLoss`	$111.86M	USD	1 Quarter
Unrealized gain on Euro-denominated notes, tax expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationTax`	$330.00K	USD	1 Quarter
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-89.00K	USD	1 Quarter
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$46.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-19.33M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-22.21M	USD	1 Quarter
Unrealized gain on foreign currency exchange contracts, tax expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax`	$2.05M	USD	1 Quarter
Unrealized gain on foreign currency exchange contracts, tax expense	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax`	$1.25M	USD	1 Quarter
Unrealized gain on cross currency swaps, tax expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax`	$869.00K	USD	1 Quarter
Unrealized gain on cross currency swaps, tax expense	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationTax`	$1.04M	USD	1 Quarter
Unrealized gain on Euro-denominated notes, net of tax expense of $1,150 in 2021 and $330 in 2020	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax`	$3.65M	USD	1 Quarter
Unrealized gain on Euro-denominated notes, net of tax expense of $1,150 in 2021 and $330 in 2020	`OtherComprehensiveIncomeLossNetInvestmentHedgeEuroDenominatedNotesGainLossAfterReclassificationAndTax`	$1.05M	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax expense (benefit) of $46 in 2021 and $(89) in 2020	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-279.00K	USD	1 Quarter
Reclassification adjustment for loss (gain) included in net income, tax benefit (expense)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax`	$-536.00K	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax expense (benefit) of $46 in 2021 and $(89) in 2020	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$147.00K	USD	1 Quarter
Reclassification adjustment for loss (gain) included in net income, tax benefit (expense)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax`	$240.00K	USD	1 Quarter
Unrealized gain on foreign currency exchange contracts, net of tax expense of $1,249 in 2021 and $2,052 in 2020	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$9.43M	USD	1 Quarter
Unrealized gain on foreign currency exchange contracts, net of tax expense of $1,249 in 2021 and $2,052 in 2020	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$4.42M	USD	1 Quarter
Unrealized gain on cross currency swaps, net of tax expense of $1,043 in 2021 and $869 in 2020	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax`	$3.31M	USD	1 Quarter
Unrealized gain on cross currency swaps, net of tax expense of $1,043 in 2021 and $869 in 2020	`OtherComprehensiveIncomeLossNetInvestmentHedgeCrossCurrencySwapsGainLossBeforeReclassificationAfterTax`	$4.05M	USD	1 Quarter
Reclassification adjustment for loss (gain) included in net income, net of tax benefit (expense) of $536 in 2021 and $(240) in 2020	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$-1.89M	USD	1 Quarter
Reclassification adjustment for loss (gain) included in net income, net of tax benefit (expense) of $536 in 2021 and $(240) in 2020	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$1.10M	USD	1 Quarter
Unrealized gain on derivative instruments	`OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax`	$12.37M	USD	1 Quarter
Unrealized gain on derivative instruments	`OtherComprehensiveIncomeLossCashFlowHedgeAndNetInvestmentHedgeGainLossAfterReclassificationAndTax`	$9.62M	USD	1 Quarter
Other comprehensive (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.06M	USD	1 Quarter
Other comprehensive (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-5.92M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$198.37M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$102.79M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$32.00K	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$29.00K	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$198.34M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$102.76M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.